Forward Pharma Loses Patent Appeal Against Biogen

31.10.2018 - A US federal appeals court has rejected an appeal by Danish biopharma Forward Pharma against the validity of Biogen’s patent for blockbuster multiple sclerosis (MS) drug Tecfidera...